Main Page Side Effects Insurance Coverage Review Board

Does Blue Cross Blue Shield Michigan Cover Ozempic for Weight Loss?

Does Blue Cross Blue Shield Michigan Cover Ozempic? Michigan BCBS Coverage Guide 2026

If you live in Michigan trying to find out if your Blue Cross Blue Shield plan covers Ozempic, the answer depends on your specific plan design. Blue Cross Blue Shield of Michigan handles coverage for millions of Michigan residents, and the formulary position on Ozempic (semaglutide) is distinct from other state BCBS affiliates.


Ozempic Tier Placement in Michigan

Blue Cross Blue Shield of Michigan operates its own formulary that doesn’t always match national BCBS formularies. In the current plan year, Ozempic is typically listed at Tier 3 (non-preferred specialty brand) across the majority of Blue Cross Blue Shield of Michigan commercial plans.

What this translates to:

  • Prior authorization is required for all plans
  • Step therapy may apply — you’ll need to fail cheaper alternatives first
  • Out-of-pocket costs generally fall between $50–$150/month based on plan design and deductible status
  • Some Michigan employer-sponsored BCBS plans may cover Ozempic at a better tier

If paying cash, Ozempic costs $850–$1,200 per month statewide.


Ozempic Coverage for Medical Conditions in Michigan

Blue Cross Blue Shield of Michigan’s coverage policies for Ozempic are shaped by the medical indication.

For type 2 diabetes (FDA-approved indication):

  • Getting covered is the standard path
  • Nearly all Michigan BCBS plans will approve Ozempic with documentation
  • What you need typically includes lab results and prescription history

For weight loss (obesity treatment):

  • Blue Cross Blue Shield of Michigan applies stricter criteria
  • Patients need to show BMI ≥30 (or ≥27 and at least one weight-related comorbidity)
  • Some Michigan plans exclude anti-obesity medications entirely

How to Get Ozempic Approved by BCBS Michigan

Getting authorization for Ozempic from Blue Cross Blue Shield of Michigan requires careful preparation.

  1. Confirm your plan’s formulary — Log into your Blue Cross Blue Shield of Michigan member portal to check Ozempic’s formulary position on your specific plan
  2. Work with your prescriber submit prior authorization — Attach diagnosis codes, lab results, and prior medication history
  3. Document inadequate response to prior therapies — Step therapy may need evidence of trying at least two first-line treatments first
  4. Challenge a denial — Blue Cross Blue Shield of Michigan offers two levels of internal appeal plus external review through

A 2024 KFF survey found that around one-third of GLP-1 prior authorization requests are initially denied but more than half win on appeal.


Alternatives if BCBS Michigan Denies Coverage

Should Blue Cross Blue Shield of Michigan denies Ozempic coverage, consider these alternatives:

  • Manufacturer savings programs — Novo Nordisk has copay assistance that bring costs down to as low as $25/month for qualifying commercially insured patients
  • 503B compounding — An option through Michigan compounders at lower prices, though BCBS won’t cover compounded versions
  • Ask about therapeutic alternatives — Blue Cross Blue Shield of Michigan may prefer an alternative in the same class
  • Michigan state pharmaceutical assistance programs — Check whether Michigan has any state-run prescription programs for high-cost medications

Bottom Line for Michigan BCBS Members

Blue Cross Blue Shield of Michigan does cover Ozempic — the path to coverage is plan-specific and often requires meeting specific clinical criteria. Begin with calling member services and coordinating with your doctor to document medical necessity thoroughly.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.